GAUSH MEDITECH (02407): The artificial lens implant system has obtained the Chinese medical device registration certificate.

GAUSH MEDITECH (02407) announces that its wholly-owned subsidiary Gsight Medical Technology Co., Ltd. ("Gsight") has recently obtained a medical device registration certificate approved by the Guangdong Provincial Drug Administration for its "Intraocular Lens Implantation System". According to the content of the "Chinese Adult Cataract Removal Surgery Guidelines (2023)", cataract is the leading cause of blindness worldwide. The artificial intraocular lens implantation system approved this time by Gsight (registration number: Guangdong Xie Certified 20252160605) is mainly used for the implantation of artificial intraocular lenses in micro-incision cataract surgeries. Compared to the artificial intraocular lens implantation system approved in 2024 (registration number: Guangdong Xie Certified 20242161490), it optimizes the surgical incision to be within 1.8mm, minimizing corneal trauma and speeding up postoperative recovery. Additionally, its introduction head surface uses chemical graft lubrication coating technology to achieve ultra-low resistance in lens injection, significantly improving surgical efficiency. This product is an original design by Gsight and has been granted invention patents. The technical feature of this invention patent is that it can install different models of insertion heads on its main body sheath for use in the implantation of lenses of different sizes for different surgical incision sizes. It can also be expanded into a pre-loaded implantation system to adapt to all types of artificial intraocular lenses on the market for intraocular lens implantation surgeries.